Last reviewed · How we verify
NCT06718478
First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis
NA trial testing SakuraBead Resorbable Microspheres in Osteoarthritis (OA) of the Knee in 15 participants. Completed in 23 August 2024.
28 March 2024
Quick facts
| Lead sponsor | CrannMed |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 5 December 2023 |
| Primary completion | 28 March 2024 |
| Estimated completion | 23 August 2024 |
| Sites | 1 location across Uzbekistan |
Drugs / interventions tested
- SakuraBead Resorbable Microspheres
Conditions studied
- Osteoarthritis (OA) of the Knee — all drugs for Osteoarthritis (OA) of the Knee →
- Osteoarthritis Knee Pain — all drugs for Osteoarthritis Knee Pain →
- Joint Diseases — all drugs for Joint Diseases →
- Musculoskeletal Diseases — all drugs for Musculoskeletal Diseases →
Sponsor
CrannMed — full company profile →
Who can join
40 and older, any sex, with Osteoarthritis (OA) of the Knee or Osteoarthritis Knee Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, single-centre, single-arm, unmasked, First in Human study that aims to evaluate the safety and efficacy of SakuraBead resorbable microspheres in adult patients suffering from pain secondary to knee osteoarthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06718478
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Osteoarthritis (OA) of the Knee
Currently open trials in the same condition.
- NCT07231471 — Platelet Rich Plasma for Musculoskeletal Conditions · NA · recruiting
- NCT06929871 — Mako Cementless TKA vs Mako Cemented TKA · NA · recruiting
- NCT06865079 — 53-Week Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 With Mild to Severe Tibio-Femo · Phase 2 · active not recruiting
- NCT06702046 — The Efficacy of Transcutaneous Pulsed Radiofrequency Acupuncture for Knee Osteoarthritis · NA · recruiting
- NCT06805188 — Clinical Study of Acupuncture Treatment of Knee Osteoarthritis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06718478 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CrannMed
- Last refreshed: 5 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06718478.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing